Drug Profile
LGD 1550
Alternative Names: ALRT 1550; ALRT 550; LG 1550Latest Information Update: 19 May 2020
Price :
$50
*
At a glance
- Originator Allergan; Ligand Pharmaceuticals
- Class Retinoids; Small molecules
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne; Cervical cancer; Haematological malignancies; Head and neck cancer; Psoriasis; Solid tumours
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 10 Jul 2007 Discontinued - Phase-II for Cervical cancer in USA (PO)
- 10 Jul 2007 Discontinued - Phase-II for Haematological malignancies in USA (PO)